Your browser doesn't support javascript.
loading
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study.
Papp, Kim; Bachelez, Herve; Costanzo, Antonio; Foley, Peter; Gooderham, Melinda; Kaur, Primal; Narbutt, Joanna; Philipp, Sandra; Spelman, Lynda; Weglowska, Jolanta; Zhang, Nan; Strober, Bruce.
Afiliação
  • Papp K; K Papp Clinical Research, Waterloo, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: kapapp@probitymedical.com.
  • Bachelez H; Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, Assistance Publique-Hopitaux de Paris Saint-Louis Hospital, Paris, France.
  • Costanzo A; Dermatology Unit, Department of Neuroscience, Mental Health and Sensory Systems (NeSMOS) Department, Sapienza University of Rome, Rome, Italy.
  • Foley P; Probity Medical Research, Carlton, Australia; Department of Medicine (Dermatology), University of Melbourne, St Vincent's Hospital Melbourne, Skin and Cancer Foundation Inc, Melbourne, Australia.
  • Gooderham M; Probity Medical Research, Waterloo, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada.
  • Kaur P; Amgen Inc, Thousand Oaks, California.
  • Narbutt J; Dermoklinika Medical Centre, Lodz, Poland.
  • Philipp S; Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany.
  • Spelman L; Probity Medical Research, Woolloongabba, Australia; Veracity Clinical Research, Woolloongabba, Australia.
  • Weglowska J; Regional Hospital, Department of Dermatology, Wroclaw, Poland.
  • Zhang N; Amgen Inc, Thousand Oaks, California.
  • Strober B; Probity Medical Research, Farmington, Connecticut; University of Connecticut Health Center, Connecticut.
J Am Acad Dermatol ; 76(6): 1093-1102, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28291552

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Medicamentos Biossimilares / Adalimumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Medicamentos Biossimilares / Adalimumab Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2017 Tipo de documento: Article